Mytos (formerly Cytera CellWorks) is a verifiable, high-potential biotechnology company backed by Y Combinator and ~$30M in funding (Series A). The project addresses a critical bottleneck in biopharma: automating cell culture. While the external reality of the project is exceptional (innovative hardware, strong backing, clear utility), the submission itself was of extremely low quality, containing false claims ('everyone', 'most people have used my product') and lazy data entry. The score reflects the high real-world value and traction of the company, heavily verified through external search, but includes penalties for the poor submission accuracy.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline